The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van der Heyde, H. C.
Right arrow Articles by Weidanz, W. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van der Heyde, H. C.
Right arrow Articles by Weidanz, W. P.

The Journal of Immunology, Vol 152, Issue 9 4557-4562, Copyright © 1994 by American Association of Immunologists


ARTICLES

The resolution of acute malaria in a definitive model of B cell deficiency, the JHD mouse

HC van der Heyde, D Huszar, C Woodhouse, DD Manning and WP Weidanz
Department of Medical Microbiology and Immunology, University of Wisconsin, Madison 53706.

Because the role of cell-mediated immunity (CMI) in the resolution of blood-stage malaria remains unclear, we examined the question of whether mice completely lacking Ab-mediated immunity (AMI) but possessing some CMI can resolve experimental malaria previously reported not to require AMI for resolution. Severe combined immunodeficient mice reconstituted with enriched immune T cells (< 0.5% B220+ cells) suppressed acute Plasmodium chabaudi adami parasitemia, suggesting that T, but not B, cells are required to clear this form of malaria. In addition, JHD mice, which are a definitive model of B cell deficiency, were also shown to resolve P. chabaudi adami, Plasmodium vinckei petteri and Plasmodium chabaudi chabaudi malaria. These observations collectively establish that CMI alone can mediate the clearance of acute malaria caused by these subspecies of Plasmodium. Moreover, the protective cell-mediated immune response involved depends upon CD4+ T cells because JHD mice treated with anti-CD4 mAb do not resolve their infections. These results suggest that evaluation of immunization regimens to activate CD4+ T cell dependent cell mediated immunity against Plasmodium falciparum may be appropriate.


This article has been cited by other articles:


Home page
J. Immunol.Home page
E. Belnoue, T. Voza, F. T. M. Costa, A. C. Gruner, M. Mauduit, D. S. Rosa, N. Depinay, M. Kayibanda, A. M. Vigario, D. Mazier, et al.
Vaccination with Live Plasmodium yoelii Blood Stage Parasites under Chloroquine Cover Induces Cross-Stage Immunity against Malaria Liver Stage
J. Immunol., December 15, 2008; 181(12): 8552 - 8558.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. M. Petritus and J. M. Burns Jr.
Suppression of Lethal Plasmodium yoelii Malaria following Protective Immunization Requires Antibody-, IL-4-, and IFN-{gamma}-Dependent Responses Induced by Vaccination and/or Challenge Infection
J. Immunol., January 1, 2008; 180(1): 444 - 453.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
H. C. van der Heyde, J. M. Batchelder, M. Sandor, and W. P. Weidanz
Splenic {gamma}{delta} T Cells Regulated by CD4+ T Cells Are Required To Control Chronic Plasmodium chabaudi Malaria in the B-Cell-Deficient Mouse.
Infect. Immun., May 1, 2006; 74(5): 2717 - 2725.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
T. M Strutt, J. Uzonna, K. K McKinstry, and P. A Bretscher
Activation of thymic T cells by MHC alloantigen requires syngeneic, activated CD4+ T cells and B cells as APC
Int. Immunol., May 1, 2006; 18(5): 719 - 728.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. Stephens, F. R. Albano, S. Quin, B. J. Pascal, V. Harrison, B. Stockinger, D. Kioussis, H.-U. Weltzien, and J. Langhorne
Malaria-specific transgenic CD4+ T cells protect immunodeficient mice from lethal infection and demonstrate requirement for a protective threshold of antibody production for parasite clearance
Blood, September 1, 2005; 106(5): 1676 - 1684.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
A. Rainczuk, T. Scorza, T. W. Spithill, and P. M. Smooker
A Bicistronic DNA Vaccine Containing Apical Membrane Antigen 1 and Merozoite Surface Protein 4/5 Can Prime Humoral and Cellular Immune Responses and Partially Protect Mice against Virulent Plasmodium chabaudi adami DS Malaria
Infect. Immun., October 1, 2004; 72(10): 5565 - 5573.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
J. M. Burns Jr., P. R. Flaherty, P. Nanavati, and W. P. Weidanz
Protection against Plasmodium chabaudi Malaria Induced by Immunization with Apical Membrane Antigen 1 and Merozoite Surface Protein 1 in the Absence of Gamma Interferon or Interleukin-4
Infect. Immun., October 1, 2004; 72(10): 5605 - 5612.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
T. Rummel, J. Batchelder, P. Flaherty, G. LaFleur, P. Nanavati, J. M. Burns, and W. P. Weidanz
CD28 Costimulation Is Required for the Expression of T-Cell-Dependent Cell-Mediated Immunity against Blood-Stage Plasmodium chabaudi Malaria Parasites
Infect. Immun., October 1, 2004; 72(10): 5768 - 5774.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. H. Achtman, M. Khan, I. C. M. MacLennan, and J. Langhorne
Plasmodium chabaudi chabaudi Infection in Mice Induces Strong B Cell Responses and Striking But Temporary Changes in Splenic Cell Distribution
J. Immunol., July 1, 2003; 171(1): 317 - 324.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. C. van der Heyde, Y. Gu, Q. Zhang, G. Sun, and M. B. Grisham
Nitric Oxide Is Neither Necessary Nor Sufficient for Resolution of Plasmodium chabaudi Malaria in Mice
J. Immunol., September 15, 2000; 165(6): 3317 - 3323.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Xu, A. N. Hodder, H. Yan, P. E. Crewther, R. F. Anders, and M. F. Good
CD4+ T Cells Acting Independently of Antibody Contribute to Protective Immunity to Plasmodium chabaudi Infection After Apical Membrane Antigen 1 Immunization
J. Immunol., July 1, 2000; 165(1): 389 - 396.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
W. P. Weidanz, J. R. Kemp, J. M. Batchelder, F. K. Cigel, M. Sandor, and H. C. v. d. Heyde
Plasticity of Immune Responses Suppressing Parasitemia During Acute Plasmodium chabaudi Malaria
J. Immunol., June 15, 1999; 162(12): 7383 - 7388.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. M. G. Seixas and J. Langhorne
{gamma}{delta}T Cells Contribute to Control of Chronic Parasitemia in Plasmodium chabaudi Infections in Mice
J. Immunol., March 1, 1999; 162(5): 2837 - 2841.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
M. M. Mota, K. N. Brown, A. A. Holder, and W. Jarra
Acute Plasmodium chabaudi chabaudi Malaria Infection Induces Antibodies Which Bind to the Surfaces of Parasitized Erythrocytes and Promote Their Phagocytosis by Macrophages In Vitro
Infect. Immun., September 1, 1998; 66(9): 4080 - 4086.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1994 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1994 by The American Association of Immunologists, Inc. All rights reserved.